Daniel Green

Daniel Green is a seasoned entrepreneur and executive with over 30 years of experience in the biotechnology and digital health sectors. He is currently the Chairman, CEO, and Founder of Espraye, Inc., a company he established in September 2023.1 Espraye focuses on developing novel spray-dried inhaled formulations of Active Pharmaceutical Ingredients (APIs), initially targeting orphan respiratory diseases.1

Throughout his career, Green has co-founded and led several startups:

1. Espraye, Inc. (September 2023 - Present): Developing inhaled drug formulations for rapid and safe drug absorption.1
2. Pixihealth (January 2018 - December 2021): A digital health platform for managing chronic diseases.1
3. Enject, Inc. (October 2008 - 2015): Developed a glucagon auto-injector for severe hypoglycemia in diabetic patients.1
4. DiObex, Inc. (October 2002 - September 2007): Focused on diabetes treatment, raised $33 million in venture funding.1

Green has a strong background in finance, marketing, and international business, as well as a graduate degree in physiology. He speaks three languages and brings a global perspective to innovation and healthcare.1